M. Jean Franchi

Affiliations

  • at Biodesix Inc (BDSX), 2024-05-23
  • Chief Financial Officer at Disc Medicine Inc. (IRON), 2024-02-16
  • Chief Financial Officer at Replimune Group Inc. (REPL), 2023-05-19
  • Chief Financial Officer at Merrimack Pharmaceuticals Inc (MACK), 2018-12-13
  • Chief Financial Officer at Dimension Therapeutics Inc. (DMTX), 2017-02-03
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
REPL $18.05 11,351 Officer 128,748 2023-05-16 Filing
REPL $14.59 3,436 Officer 95,099 2022-05-16 Filing
REPL $44.00 600 Officer 0 2021-01-14 Filing
REPL $44.55 14,300 Officer 600 2021-01-14 Filing
REPL $44.19 100 Officer 0 2021-01-13 Filing